StorONE and Accessium Group Enhance Healthcare Data Management with High Capacity, High Performance, and HIPAA-Compliant Storage Solutions
July 23, 2024 08:00 ET
|
StorONE
New York, NY, July 23, 2024 (GLOBE NEWSWIRE) -- StorONE, the only vendor providing all enterprise storage use cases on ONE Storage Platform, and Accessium Group, a premier healthcare consulting firm...
Eyenovia and Senju Pharmaceutical Co., Ltd. Sign Collaboration Agreement for Potential New Treatment for Chronic Dry Eye Disease
July 23, 2024 07:00 ET
|
Eyenovia, Inc.
Collaboration to focus on the development of a formulation of Senju’s SJP-0035 for use with Eyenovia’s Optejet® dispensing technology, following consultation with FDA Chronic dry eye estimated to be...
Clearside Biomedical Opens Registration for Suprachoroidal Delivery KOL Webinar to Be Held on Wednesday, July 24, 2024 at 8:00 am ET
July 22, 2024 12:00 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., July 22, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the...
Lumibird: H1 2024 revenues
July 22, 2024 11:50 ET
|
Lumibird SA
Lannion, July 22, 2024– 5:45 pm H1 2024 REVENUES Slight increase to €98m (+1%) with a base effect (H1 2023 growth of +16% vs H1 2022) 3-year target maintained for revenue growth (CAGR +8%) and...
UNITY Biotechnology Announces Appointment of Alicia Tozier as Chief Strategy Officer
July 22, 2024 08:00 ET
|
Unity Biotechnology, Inc.
SAN FRANCISCO, July 22, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today...
FDA Approves Samsung Bioepis’ EPYSQLI® (eculizumab-aagh) as a Biosimilar to Soliris (eculizumab)
July 22, 2024 07:00 ET
|
Samsung Bioepis
Samsung Bioepis’ eighth biosimilar approved by the U.S. Food and Drug AdministrationEPYSQLI is approved for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical...
STADA and Alvotech launch Uzpruvo, the first approved ustekinumab biosimilar to Stelara, across Europe
July 22, 2024 06:35 ET
|
Alvotech
STADA and Alvotech launch Uzpruvo, the first approved ustekinumab biosimilar to Stelara, across Europe Launch of European-made Uzpruvo in Europe comes immediately upon expiry of exclusivity rights...
STADA and Alvotech launch Uzpruvo, the first approved ustekinumab biosimilar to Stelara, across Europe
July 22, 2024 06:30 ET
|
Alvotech
STADA and Alvotech launch Uzpruvo, the first approved ustekinumab biosimilar to Stelara, across Europe
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Skye Bioscience, Inc. - SKYE
July 20, 2024 16:50 ET
|
Pomerantz LLP
NEW YORK, July 20, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Skye Bioscience, Inc. (“Skye” or the “Company”) (NASDAQ: SKYE). Such investors are advised...
Nicox : Participation aux prochaines conférences
July 19, 2024 01:30 ET
|
NICOX SA
Communiqué de presseNicox : Participation aux prochaines conférences 19 juillet 2024 – publication at 7H30 CET Sophia Antipolis, FranceNicox SA (Euronext Growth Paris : FR0013018124, ALCOX, éligible...